Promoter hypermethylation and global hypomethylation are independent epigenetic events in lymphoid leukemogenesis with opposing effects on clinical outcome.
- Published in:
- 2006
- By:
- Publication type:
- Letter
Works matching IS 08876924 AND DT 2006 AND VI 20 AND IP 8
Results: 29
1
2
JAK2 mutation in a boy with polycythemia vera, but not in other pediatric hematologic Disorders.
- Published in:
- 2006
- By:
- Publication type:
- Letter
3
The BCL11AXL transcription factor: its distribution in normal and malignant tissues and use as a marker for plasmacytoid dendritic cells.
- Published in:
- 2006
- By:
- Publication type:
- Letter
4
Functional capacity of Mcl-1-specific cytotoxic T-cells.
- Published in:
- 2006
- By:
- Publication type:
- Letter
5
Molecular response in acute promyelocytic leukemia: a direct comparison of regular and real-time RT-PCR.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1393, doi. 10.1038/sj.leu.2404262
- By:
- Publication type:
- Article
6
Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source.
- Published in:
- 2006
- By:
- Publication type:
- Letter
7
Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1331, doi. 10.1038/sj.leu.2404264
- By:
- Publication type:
- Article
8
Alemtuzumab in combination with high-dose methylprednisolone is a logical, feasible and highly active therapeutic regimen in chronic lymphocytic leukaemia patients with p53 defects.
- Published in:
- 2006
- By:
- Publication type:
- Letter
9
Blood oxidative status and selectins plasma levels in healthy donors receiving granulocyte-colony stimulating factor.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1430, doi. 10.1038/sj.leu.2404271
- By:
- Publication type:
- Article
10
The RSD code: proposal for a nomenclature of allelic configurations in STR-PCR-based chimerism testing after allogeneic stem cell transplantation.
- Published in:
- 2006
- By:
- Publication type:
- Letter
11
Chimerism and transplant-related diagnostics.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
12
Tissue factor in hematological malignancies.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
13
Loss of heterozygosity on chromosome 6q14–q24 is associated with poor outcome in children and adolescents with T-cell lymphoblastic lymphoma.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1422, doi. 10.1038/sj.leu.2404275
- By:
- Publication type:
- Article
14
FLT3 is fused to ETV6 in a myeloproliferative disorder with hypereosinophilia and a t(12;13)(p13;q12) translocation.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1414, doi. 10.1038/sj.leu.2404266
- By:
- Publication type:
- Article
15
Granulocyte colony stimulating factor administration associated with cerebral hemorrhage in acute promyelocytic leukemia.
- Published in:
- 2006
- By:
- Publication type:
- Letter
16
Short tandem repeat markers in diagnostics: what's in a repeat?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
17
Consensus guidelines for microarray gene expression analyses in leukemia from three European leukemia networks.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1385, doi. 10.1038/sj.leu.2404274
- By:
- Publication type:
- Article
18
Gene expression signature of primary imatinib-resistant chronic myeloid leukemia patients.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1400, doi. 10.1038/sj.leu.2404270
- By:
- Publication type:
- Article
19
Protein Tyrosine Kinases. From Inhibitors to Useful Drugs.
- Published in:
- 2006
- By:
- Publication type:
- Book Review
20
Combinations of the FLT3 inhibitor CEP-701 and chemotherapy synergistically kill infant and childhood MLL-rearranged ALL cells in a sequence-dependent manner.
- Published in:
- 2006
- By:
- Publication type:
- journal article
21
Proteasome inhibitor bortezomib for the treatment of multiple myeloma.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1341, doi. 10.1038/sj.leu.2404278
- By:
- Publication type:
- Article
22
Susceptibility to myeloid and lymphoid leukemia is mediated by distinct inhibitory KIR-HLA ligand interactions.
- Published in:
- 2006
- By:
- Publication type:
- Letter
23
The role of the bax gene polymorphism G(−248)A in chronic lymphocytic leukemia.
- Published in:
- 2006
- By:
- Publication type:
- Letter
24
Development of megakaryoblastic leukaemia in Runx1-Evi1 knock-in chimaeric mouse.
- Published in:
- 2006
- By:
- Publication type:
- Letter
25
Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.
- Published in:
- 2006
- By:
- Publication type:
- Letter
26
Association of the heterozygous germline I171V mutation of the NBS1 gene with childhood acute lymphoblastic leukemia.
- Published in:
- 2006
- By:
- Publication type:
- Letter
27
Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO<sup>+</sup> acute myelogenous leukemia.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1408, doi. 10.1038/sj.leu.2404286
- By:
- Publication type:
- Article
28
Differential expression of p73 isoforms in relation to drug resistance in childhood T-lineage acute lymphoblastic leukaemia.
- Published in:
- 2006
- By:
- Publication type:
- journal article
29
Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia.
- Published in:
- Leukemia (08876924), 2006, v. 20, n. 8, p. 1361, doi. 10.1038/sj.leu.2404287
- By:
- Publication type:
- Article